TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #120 · 17 јул.
Опубликовал для вас один из своих учебных проектов моего курса про PySide2 — LaunchPanel. Это панель, которая выезжает сверху экрана когда к ней подводишь курсор. Содержит кнопки для запуска любых команд. 🔸 можно добавить любые команды 🔸 одна кнопка может содержать много вариантов одной команды. Доступ к ним через контекстное меню 🔸 панель настраивается через файлы конфига Но самое главное в этом проекте то, что почти каждая строка задокументирована!😱 Что используется в проекте? 🔸 стилизация виджетов через StyleSheet 🔸 настройка отображения окна как панели без рамок, заголовка и всего остального 🔸 использование файлов конфига 🔸 HTML текст в виджетах 🔸 анимация свойств виджета (позиция и прозрачность) 🔸 реакция виджета на курсор 🔸 запуск подпроцессов 🌎 Исходники забираем здесь Смотрите, изучайте, пользуйтесь 😉 #qt#source
Пребарај: #biotechnology
@venturevillagewall · Post #3500 · 19.12.2024 г., 13:59
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 20.12.2024 г., 09:33
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 21.12.2024 г., 10:22
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 20.12.2024 г., 09:34
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 20.12.2024 г., 09:32
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 21.12.2024 г., 10:22
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences